CLINICAL PAIN NEUROSCIENTIST TALKS ABOUT HOW THE BRAIN PROCESSES PAIN INFORMATION Trial: affects on pain and activity levels, by educating knee osteoarthritis participants in individualised exercise programs
With
Tasha Stanton,
Associate Professor of Clinical Pain Neuroscience
Group, Leader Persistent Pain Research Group (Lifelong Health)
SAHMRI (South Australian Health and Medical Research Institute) &
co-Director of IMPACT in Health, University of South Australia
SEGMENT
Filmed in Adelaide | March 2026
The Persistent Pain Research Group’s vision is to work hand-in-hand with consumers to undertake impactful research that helps better understand and treat persistent pain.
Their studies span discovery to implementation science to determine key contributors to the development and maintenance of persistent pain and to use this information to create novel brain-based interventions.
They hold expertise in developing new technologies, such as virtual and mediated reality, and translating these technologies to the clinical environment, using innovative co-design methods.
The Persistent Pain Research Group studies a variety of painful conditions, with specific focus on:
- Osteoarthritis
- Spinal pain (neck and back)
- Complex regional pain syndrome
- Phantom limb pain after amputation
Persistent pain affects one in five Australians and costs the nation an estimated $73 billion per year in health system costs, lost productivity and other financial costs.
Persistent pain also has debilitating personal costs – negatively impacting quality of life and the ability to engage in meaningful work and life activities.
Despite the enormity of this problem, very few effective treatments exist with most showing only small to moderate improvements. New treatments are desperately needed. The group believes the best way to create impactful change is to work with people with lived experience of persistent pain to devise solutions with them, not for them.
Source: SAHMRI webpage Persistent Pain Research Group
-
Stroke care advances in translated research
New nurse-led protocols for stroke patients, based on ACU research, led by the Nursing Research Institute, have resulted in changes to policy, guidelines and clinical practice in Europe and Australia. The protocols were developed through the Quality in Acute Stroke Care (QASC) Trial (published in the Lancet, 2011) to manage fever, hyperglycaemia and swallowing (FeSS) post-stroke.
-
Gaining a better understanding of perimenopause and menopause
Nearly half of women seeking help for menopause symptoms are already experiencing clinically significant distress by the time they ask for support, according to a recent national benchmark report released by Metluma.
The 2026 Australian Menopause Experience Report, based on insights from 1,468 women using Metluma’s UMA40 assessment tool, found 43% triggered at least one clinical red flag at baseline (referral to a doctor within 24-48 hours), with more than one in five presenting with multiple red flags linked to more complex symptom burden.
-
New clinical research entity first to operate across both Australia and New Zealand
Over the past 30 years, 18,000 clinical trials that have been registered in Australia, with the sector contributing $1.4 billion to Australia’s economy annually. Trials are a critical aspect of evidence-based medicine, and are essential for testing how new treatments, tests and vaccines will work. In New Zealand they contribute $146 million to the New Zealand economy.
To capitalise on this unique position and growth, a coordinated multi-site clinical research operation was missing, until now.
